The Evolution of Gene-Guided Management of Inherited Arrhythmia Syndromes: Peering Beyond Monogenic Paradigms Towards Comprehensive Genomic Risk Scores
Affiliations
- PMID: 32107815
- DOI: 10.1111/jce.14415
Abstract
Inherited arrhythmia syndromes have traditionally been viewed as monogenic forms of disease whose pathophysiology is driven by a single highly penetrant mutation. Although an accurate depiction of a proportion of genetic variants, the variable penetrance frequently noted in genotype positive families and the presence of sporadic genotype negative cases have long highlighted a more nuanced truth being operative. Coupled with our more recent recognition that many variants implicated in inherited arrhythmia syndromes possess unexpectedly high allele frequencies within the general population, these observations have contributed to the realization that a spectrum of pathogenicity exists among clinically relevant genetic variants. Notably, variable mutation pathogenicity and corresponding variable degrees of penetrance emphasize a limitation of contemporary guidelines, which attempt to dichotomize genetic variants as pathogenic or benign. Recognition of the existence of low and intermediate penetrant variants insufficient to be causative for disease in isolation has served to emphasize the importance of additional genetic, clinical, and environmental factors in the pathogenesis of rare inherited arrhythmia syndromes. Despite being rare, it has also become increasingly evident that common genetic variants play critical roles in both heritable channelopathies and cardiomyopathies and may even be the primary drivers in certain instances, such as genotype negative Brugada syndrome. Our growing realization that the genetic substrates of inherited arrhythmia syndromes have intricacies that extend beyond traditionally perceived monogenic paradigms has highlighted a potential value of leveraging more comprehensive genomic risk scores for predicting disease development and arrhythmic risk. This article is protected by copyright. All rights reserved.
Keywords: Brugada syndrome; arrhythmogenic cardiomyopathy; channelopathies; genetics; inherited arrhythmias; long-QT syndrome.
This article is protected by copyright. All rights reserved.
Similar articles
- Drug-induced Fatal Arrhythmias: Acquired Long QT and Brugada SyndromesI Turker et al. Pharmacol Ther 176, 48-59. PMID 28527921. - ReviewSince the early 1990s, the concept of primary "inherited" arrhythmia syndromes or ion channelopathies has evolved rapidly as a result of revolutionary progresses made in …
- The Atrial Phenotype of the Inherited Primary Arrhythmia SyndromesG Conte et al. Arrhythm Electrophysiol Rev 8 (1), 42-46. PMID 30918666. - ReviewOver the past two decades, our understanding of inherited primary arrhythmia syndromes has been enriched by studies that have aimed to define the clinical characteristics …
- Genetic Testing in the Management of Inherited Arrhythmia SyndromesWS Tzou et al. Curr Cardiol Rep 11 (5), 343-51. PMID 19709494. - ReviewAlthough the first gene responsible for long QT syndrome was described more than a decade ago, only now has the genetic testing become readily available to clinicians tre …
- Lack of Genotype-Phenotype Correlation in Brugada Syndrome and Sudden Arrhythmic Death Syndrome Families With Reported Pathogenic SCN1B VariantsB Gray et al. Heart Rhythm 15 (7), 1051-1057. PMID 29758173.The lack of genotype-phenotype concordance among families, combined with the high frequency of previously reported mutations in the Genome Aggregation Database browser, s …
- Determinants of Incomplete Penetrance and Variable Expressivity in Heritable Cardiac Arrhythmia SyndromesJR Giudicessi et al. Transl Res 161 (1), 1-14. PMID 22995932. - ReviewMutations in genes encoding ion channel pore-forming α-subunits and accessory β-subunits as well as intracellular calcium-handling proteins that collectively maintain the …
.png)
No hay comentarios:
Publicar un comentario